SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of ANSYS to Synopsys SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of ANSYS, Inc. (NASDAQ: ANSS) (“ANSYS” or...

Response to Novel Immune Therapy for Ulcerative Colitis Associated with Genetic and Immune Biomarkers VANCOUVER, British Columbia , Oct. 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...